DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam flag Vietnam · Delayed Price · Currency is VND
83,800
-1,000 (-1.18%)
At close: Nov 3, 2026

DHG Pharmaceutical JSC Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
852,416852,354778,9201,050,663988,455777,220
Depreciation & Amortization
117,210118,029169,69588,70481,00182,564
Other Amortization
1,041978.85---1,299
Loss (Gain) From Sale of Assets
-99,481-120,583-139,127-203,609-112,319-106,218
Other Operating Activities
56,86917,665-9,538-11,828-56,715-43,544
Change in Accounts Receivable
-41,249-54,941105,103-268,58934,20622,427
Change in Inventory
-234,73886,655420,960-286,890-177,950-246,313
Change in Accounts Payable
76,297289,927-21,510-129,051160,321-33,242
Change in Other Net Operating Assets
-22,97522,88213,080772.15-15,714-1,749
Operating Cash Flow
705,3891,212,9681,317,583240,171901,285452,444
Operating Cash Flow Growth
-43.67%-7.94%448.60%-73.35%99.20%-45.24%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-85,536-31,136-88,705-486,343-233,992-24,562
Sale of Property, Plant & Equipment
1,0841,240967.731,6543,3344,632
Investment in Securities
----3,20684.72
Other Investing Activities
131,340120,628156,786179,869118,723101,430
Investing Cash Flow
1,281,906811,731-445,951-179,819-353,72945,694

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,321,4471,708,0851,524,390737,941794,683
Total Debt Issued
-190,2661,321,4471,708,0851,524,390737,941794,683
Short-Term Debt Repaid
--1,971,361-1,630,335-1,066,949-830,609-799,564
Total Debt Repaid
-688,955-1,971,361-1,630,335-1,066,949-830,609-799,564
Net Debt Issued (Repaid)
-879,221-649,91477,749457,441-92,668-4,880
Common Dividends Paid
-1,307,461-1,307,461-980,596-457,611-457,611-522,984
Financing Cash Flow
-2,186,682-1,957,375-902,846-170.11-550,279-527,865

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-319.63-286.21-62.53-65.74-222.1945.25
Net Cash Flow
-199,70667,038-31,27660,116-2,946-29,681

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
619,8531,181,8311,228,879-246,171667,293427,882
Free Cash Flow Growth
-47.52%-3.83%--55.95%-41.97%
Free Cash Flow Margin
11.64%22.44%25.16%-4.91%14.27%10.69%
Free Cash Flow Per Share
4740.909039.139398.97-1882.825103.733272.62
Levered Free Cash Flow
570,441554,1121,955,870-506,459447,363260,730
Unlevered Free Cash Flow
572,315570,1341,971,377-488,003455,212268,280

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3,47726,02024,76629,29912,55812,050
Cash Income Tax Paid
137,579124,797101,297104,854100,99999,613
Change in Working Capital
-222,665344,523517,633-683,758862.86-258,877